NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) Institutional Ownership

13F Institutional Holders and Ownership History for Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
NXTC on Nasdaq
Shares outstanding
2,676,179
Price per share
$12.55
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
836,243
Total reported value
$4,898,495
% of total 13F portfolios
0%
Share change
+836,211
Value change
+$4,898,307
Number of holders
16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Simcere Zaiming, Inc. 13% $1,747,362 338,636 Simcere Zaiming, Inc. 20 Jun 2025
Affinity Asset Advisors, LLC 7.2% $1,122,510 191,882 Affinity Healthcare Fund, LP 30 Sep 2025
Squadron Capital Management LLC 6.5% $1,017,087 173,861 Squadron Capital Management LLC 21 Oct 2025

As of 30 Sep 2025, 16 institutional investors reported holding 836,243 shares of NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC). This represents 31% of the company’s total 2,676,179 outstanding shares.

Top 16 Institutional Shareholders

The largest institutional shareholders of NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) together control 31% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Sofinnova Investments, Inc. 8.3% 222,654 0.08% $1,304,752
Affinity Asset Advisors, LLC 7.2% 191,882 0.1% $1,124,429
Pfizer Inc 5.9% 157,646 0.21% $923,806
VANGUARD GROUP INC 2.5% 67,983 0% $398,380
Cable Car Capital, LP 2.4% 63,178 0.16% $370,223
ACADIAN ASSET MANAGEMENT LLC 1.4% 36,675 0% $213,000
BlackRock, Inc. 1.2% 31,086 0% $182,165
RENAISSANCE TECHNOLOGIES LLC 1.1% 28,334 0% $166,037
GEODE CAPITAL MANAGEMENT, LLC 0.73% 19,521 0% $114,420
Sio Capital Management, LLC 0.41% 10,940 0.02% $64,108
BARCLAYS PLC 0.21% 5,626 0% $32,968
UBS Group AG 0.02% 601 0% $3,522
JPMORGAN CHASE & CO 0% 61 0% $357
BNP PARIBAS FINANCIAL MARKETS 0% 32 0% 0% $188
BANK OF AMERICA CORP /DE/ 0% 23 0% $134
CITIGROUP INC 0% 1 0% $6

Institutional Holders of NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 836,243 $4,898,495 +$4,898,307 $5.86 16